usaid world health organization adult drug-resistant tb ... - stoptb gdf...adult drug-resistant tb...
Post on 28-Jul-2021
3 Views
Preview:
TRANSCRIPT
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Amikacin1000mgvial
Amikacin100mgvial
Amikacin500mg/2mLvial
Amoxicillin/clavulanate500mg/125mgtablet
Bedaquiline100mgtablet
Clofazimine100mgtablet/capsule
Clofazimine50mgtablet/capsule
Cycloserine250mgcapsule
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Clofazimine50mgtablet/capsule
Cycloserine250mgcapsule
Delamanid50mgtablet
Ethambutol400mgtablet/capsule
Ethionamide250mgtablet/capsule
Gatifloxacin200mgtablet
Gatifloxacin400mgtablet
Imipenem/cilastatin250/250mgvial
Imipenem/cilastatin500/500mgvial
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Imipenem/cilastatin250/250mgvial
Imipenem/cilastatin500/500mgvial
Imipenem/cilastatin/clavulanate500/500/125mgvial
Isoniazid300mgtablet/capsule
Levofloxacin250mgtablet/capsule
Levofloxacin500mgtablet/capsule
Levofloxacin750mgtablet/capsule
Linezolid400mgtablet
Linezolid600mgtablet
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Linezolid400mgtablet
Linezolid600mgtablet
Linezolidinjection2mg/mLin300mLbag
Meropenem1000mgvial
Meropenem500mgvial
Meropenem/clavulanate1000mg/125mgvial
Moxifloxacin400mgtablet/capsule
PAS4gmgranules
PAS500mgtablet
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
PAS4gmgranules
PAS500mgtablet
PASSodium100gmpowder
PASSodium4gm/5.52gmpowder
PASSodium4gm/9.2gmpowder
Pretomanid200mgtablet
Protionamide250mgtablet/capsule
Pyrazinamide150mgtabletscored
Pyrazinamide400mgtablet/capsule
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Pyrazinamide150mgtabletscored
Pyrazinamide400mgtablet/capsule
Pyrazinamide500mgtablet/capsule
Streptomycin1000mgvial
Terizidone250mgtablet/capsule
Terizidone500mgtablet
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
WHOGuidelines
(LTB
I'18)
WHOGuidelines
(LTB
I'20)
Ethambutol400mgtablet/capsule
Ethambutol/Isoniazid/Pyrazinamide/Rifampicin275/75/400/150mgtablet/capsule
Ethambutol/Isoniazid/Rifampicin275/75/150mgtablet/capsule
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Isoniazid/Pyrazinamide/Rifampicin75/400/150mgtablet/capsule
Isoniazid/Rifampicin75/150mgtablet/capsule
Isoniazid/Rifampicin150/300mgtablet/capsule
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
AdultDrug-SensitiveTBDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
WHOGuidelines
(LTB
I'18)
WHOGuidelines
(LTB
I'20)
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
Pyrazinamide400mgtablet/capsule
Pyrazinamide500mgtablet/capsule
Rifabutin150mgcapsule
Rifampicin150mgcapsule
Rifampicin300mgcapsule
Rifapentine150mgtablet
Rifapentine300mg
Rifapentine/Isoniazid300mg/300mgtablet
AdultDrug-SensitiveTBDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Isoniazid300mgtablet/capsule
Isoniazid/Rifampicin75/150mgtablet/capsule
Isoniazid/Rifampicin150/300mgtablet/capsule
Rifampicin150mgcapsule
Rifampicin300mgcapsule
Rifapentine150mgtablet
Rifapentine300mg
Rifapentine/Isoniazid300mg/300mgtablet
Sulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine 800/160/300/25mg tablet
AdultLatentTBInfectionDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Rifapentine/Isoniazid 300mg/300mgtabletSulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine800/160/300/25mgtablet
AdultLatentTBInfectionDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Amikacin100mgvial
Amikacin500mg/2mLvial
Amikacin1000mgvial
Amoxicillin/clavulanate500mg/125mgtablet
Amoxicillin/clavulanicacid125mg/31.25mg/5mLoralsuspension
Amoxicillin/clavulanicacid250mg/62.5mg/5mLoralsuspension
Bedaquiline20mgtablet
Bedaquiline100mgtablet
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Bedaquiline20mgtablet
Bedaquiline100mgtablet
Clofazimine50mgtablet/capsule
Cycloserine125mgcapsule
Delamanid25mgdispersibletablet
Delamanid50mgdispersibletablet
Delamanid50mgtablet
Ethambutol25mg/mLoralliquid
Ethambutol50mgdispersibletablet
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Ethambutol25mg/mLoralliquid
Ethambutol50mgdispersibletablet
Ethambutol100mgdispersibletablet
Ethambutol100mgtablet
Ethionamide125mgdispersibletablet
Ethionamide125mgtablet/capsule
Isoniazid50mgdispersibletablet
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
Isoniazid100mgdispersibletablet
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Levofloxacin100mgdispersibletablet
Linezolid20mg/mLoralsuspension
Linezolid150mgdispersibletablet
Linezolid400mgtablet
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Linezolid 150mg dispersibletablet
Linezolid400mgtablet
Linezolid600mgtablet
Linezolidinjection2mg/mLin300mLbag
Meropenem500mgvial
Meropenem1000mgvial
Meropenem/clavulanate1000mg/125mgvial
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Moxifloxacin 100mg dispersibletablet
Moxifloxacin400mgtablet/capsule
PAS4gmgranules
PAS500mgtablet
PASSodium4gm/5.52gmpowder
PASSodium4gm/9.2gmpowder
PASSodium100gmpowder
Pretomanid200mgtablet
Pyrazinamide30mg/mLoralliquid
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Pretomanid200mgtablet
Pyrazinamide30mg/mLoralliquid
Pyrazinamide150mgdispersibletablet
Pyrazinamide150mgtabletscored
Streptomycin1000mgvial
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Ethambutol25mg/mLoralliquid
Ethambutol50mgdispersibletablet
Ethambutol100mgdispersibletablet
Ethambutol100mgtablet
Isoniazid50mgdispersibletablet
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
Isoniazid100mgdispersibletablet
Isoniazid100mgtablet
PediatricDrug-SensitiveTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Isoniazid 100mg dispersibletablet
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
Pyrazinamide30mg/mLoralliquid
Pyrazinamide150mgdispersibletablet
Pyrazinamide150mgtabletscored
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersible tablet
PediatricDrug-SensitiveTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersibletablet
Rifampicin/Isoniazid/Pyrazinamide75/50/150mgdispersibletablet
Rifapentine150mgdispersibletablet
Rifapentine150mgtablet
Rifapentine300mg
Rifapentine/Isoniazid300mg/300mgtablet
PediatricDrug-SensitiveTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI
(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundList
ofPharmaceutical
Products
GlobalFundERP
EOI(Nov2020)
GlobalFundERP
approved
GDFCatalog
Isoniazid50mgdispersibletablet
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
Isoniazid100mgdispersibletablet
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Levofloxacin100mgdispersibletablet
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersible tablet
PediatricLatentTBInfectionMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI
(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundList
ofPharmaceutical
Products
GlobalFundERP
EOI(Nov2020)
GlobalFundERP
approved
GDFCatalog
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersibletablet
Rifapentine150mgdispersibletablet
Rifapentine300mg
Sulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine400/80/150/12.5mgtablet
PediatricLatentTBInfectionMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Amoxicillin/clavulanate875mg/125mgtablet
Bedaquiline100mgdispersabletablet
Capreomycin500mgvial
Capreomycin750mgvial
Capreomycin1000mgvial
Ethambutol200mgtablet/capsule
Ethambutol275mgtablet/capsule
Ethambutol1000mgvial
Ethambutol2000mgvial
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Ethambutol1000mgvial
Ethambutol2000mgvial
Ethambutol/Isoniazid400/150mgtablet/capsule
Isoniazid100mg/5mLoralliquid
Isoniazid100mg/mLvial
Isoniazid/Pyrazinamide/Rifampicin150/500/150mgtablet/capsule
Isoniazid/Rifampicin150/150mgtablet/capsule
Kanamycin500mgvial
Kanamycin1000mgvial
PASInjection
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Kanamycin1000mgvial
PASInjection
Pyrazinamide250mgtablet/capsule
Rifampicin450mgtablet
Rifampicin600mgvial
Rifapentine300mgscored,dispersible
Rifapentine/Isoniazid150mg/150mgdispersibletablet
Rifapentine/Isoniazid300mg/300mgdispersibletablet
Streptomycin750mgvial
Terizidone300mgtablet/capsule
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Streptomycin750mgvial
Terizidone300mgtablet/capsule
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
top related